Vivos (RDGL) Operating Margin Growth (1y) (2011 - 2025)
Vivos (RDGL) Operating Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn | -313.00 |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 241.00 |
| 10 | Vivos | 27.30 Mn | 25.74 Mn | -3,105.00 | 882,246.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 882,246.00 |
| Sep 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | -62,952.00 |
| Mar 31, 2025 | 959,669.00 |
| Sep 30, 2024 | -703,957.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | -868,646.00 |
| Sep 30, 2023 | -556,079.00 |
| Jun 30, 2023 | -656,741.00 |
| Mar 31, 2023 | 161,131.00 |
| Sep 30, 2022 | -295,547.00 |
| Sep 30, 2021 | 52,779.00 |
| Sep 30, 2020 | 575,523.00 |
| Mar 31, 2017 | 783,957.00 |
| Sep 30, 2016 | -1.40 Mn |
| Mar 31, 2016 | -1.41 Mn |
| Mar 31, 2015 | 115,500.00 |
| Mar 31, 2014 | 214,576.00 |
| Sep 30, 2013 | 307,091.00 |
| Mar 31, 2013 | -453,231.00 |